| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |